// App-Quantinova.ai

: No treatment effects of oral glucosamine for subgroups of knee and hip osteoarthritis patients; an individual patient data meta-analysis from the OA trial bank

Researchers

Presenter

  • J. Runhaar

Principal Investigators

  • R. Rozendaal

  • M. van Middelkoop

  • J.W. Bijlsma

  • M. Doherty

  • K. Dziedzic

  • L.S. Lohmander

  • T. McAlindon

  • W. Zhang

  • S.M. Bierma-Zeinstra

Medical Centers

  • Erasmus MC, Univ. Med. Ctr., Rotterdam, the Netherlands

  • Univ. Med. Ctr. (UMC) Utrecht, Utrecht, Netherlands

  • University of Nottingham, Nottingham, United Kingdom

  • Keele University, Keele, United Kingdom

  • Lund Univ., Lund, Sweden.

Locations

  • Netherlands

  • United Kingdom

  • Sweden

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • Body mass index

Drug/Treatment

  • Glucosamine

Outcome

  • N/A


Study Design

  • Randomized

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A